Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Rund 40 Mio. USD Staatsaufträge bis Juni 2029 gebucht: Jetzt zählt die Marge!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
01.10.BioMarin and Profluent partner on AI-designed enzyme therapies
30.09.Atossa plans shareholder stake in potential PRV proceeds
30.09.OBIO marks $704m funding milestone for Canadian health tech ventures
30.09.Kyowa Kirin, Knight agree Latin American distribution deal for mogamulizumab
29.09.Novo outlays $2.6bn in Hengrui deal to bolster oral obesity pipeline
29.09.MSD bets $2.13bn on SciBrunch's KRAS (ON) inhibitor
29.09.AstraZeneca to invest $2bn in Summit for ADC combination therapies
29.09.Tolerance Bio signs $560m worldwide TLB-33 deal with Tanabe Pharma
28.09.AbbVie lands FDA approval for next-generation Parkinson's drug, Juvmo
28.09.Novo inks $1.33bn long-lasting injectable pact with Sweden-based Nanexa
28.09.Daiichi Sankyo, MSD withdraw cancer drug application
28.09.Mirum and Incyte's Atebrioz approved for FOP in US
25.09.Aptar Pharma and Macquarie University partner on drug delivery project
25.09.FDA commissioner nominee affirms MMR vaccine safety despite Trump's claims
25.09.Roche and Earendil forge $1.5bn bispecific discovery deal
25.09.Amberstone and Henlius agree to develop solid-tumour T-cell engagers
25.09.FDA approves Lilly's Onswik for type 2 diabetes in adults
24.09.Eli Lilly outlays $3.35bn for secretive drug discovery pact with China's InnoCare
24.09.Australia starts investigation into OpenAI Medicare breach
24.09.Enveda nabs $311m to progress nature-derived drug pipeline
24.09.Genialis and Inventia to enhance pancreatic cancer treatment testing
24.09.Basecamp Research secures $140m for AI-driven therapies
23.09.European big pharma unites amid 'ringing alarm bells' of continent's dominance
23.09.Boehringer and Envisagenics to develop precision cancer therapies in $1bn deal
23.09.BoomRay and Novartis Pharma sign $900m deal for radioligand therapy